Turner, M. C., Cerullo, M., Adam, M., Shah, K. N., Blazer, D. G., Abbruzzese, J. L., & Zani, S. (2018). Adjuvant Chemotherapy Should Follow Pancreaticoduodenectomy for Pancreatic Adenocarcinoma, Despite Delays. In Journal of the American College of Surgeons (Vol. 227, pp. S169–S169). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1016/j.jamcollsurg.2018.07.359

Turner, Megan C., Marcelo Cerullo, Mohamed Adam, Kevin N. Shah, Dan G. Blazer, James L. Abbruzzese, and Sabino Zani. “Adjuvant Chemotherapy Should Follow Pancreaticoduodenectomy for Pancreatic Adenocarcinoma, Despite Delays.” In Journal of the American College of Surgeons, 227:S169–S169. Ovid Technologies (Wolters Kluwer Health), 2018. https://doi.org/10.1016/j.jamcollsurg.2018.07.359.

Turner MC, Cerullo M, Adam M, Shah KN, Blazer DG, Abbruzzese JL, et al. Adjuvant Chemotherapy Should Follow Pancreaticoduodenectomy for Pancreatic Adenocarcinoma, Despite Delays. In: Journal of the American College of Surgeons. Ovid Technologies (Wolters Kluwer Health); 2018. p. S169–S169.

Turner, Megan C., et al. “Adjuvant Chemotherapy Should Follow Pancreaticoduodenectomy for Pancreatic Adenocarcinoma, Despite Delays.” Journal of the American College of Surgeons, vol. 227, no. 4, Ovid Technologies (Wolters Kluwer Health), 2018, pp. S169–S169. Crossref, doi:10.1016/j.jamcollsurg.2018.07.359.

Turner MC, Cerullo M, Adam M, Shah KN, Blazer DG, Abbruzzese JL, Zani S. Adjuvant Chemotherapy Should Follow Pancreaticoduodenectomy for Pancreatic Adenocarcinoma, Despite Delays. Journal of the American College of Surgeons. Ovid Technologies (Wolters Kluwer Health); 2018. p. S169–S169.